PRESPECT: Follow-Up of the Prevision® Hip Stem

Sponsor
Aesculap AG (Industry)
Overall Status
Recruiting
CT.gov ID
NCT04833634
Collaborator
(none)
80
1
18.6
4.3

Study Details

Study Description

Brief Summary

The main objective of this study is to represent the treatment reality at the study site and to draw conclusions from cases of failure or suboptimal outcome. Potential risk factors for revision surgery, suboptimal outcome or radiologic sign of loosening, bone non-union or stem subsidence will be evaluated. Next to the functional outcome, stem subsidence will be used as an important indicator for a stable fixation of the revision stem.

Study Design

Study Type:
Observational
Anticipated Enrollment :
80 participants
Observational Model:
Case-Only
Time Perspective:
Retrospective
Official Title:
Retrospective Follow-Up of the Prevision® Hip Stem in a Consecutive Case Series
Actual Study Start Date :
May 14, 2021
Anticipated Primary Completion Date :
Sep 1, 2022
Anticipated Study Completion Date :
Dec 1, 2022

Outcome Measures

Primary Outcome Measures

  1. Hip stem survival measured by Kaplan-Meier [One scheduled Follow-Up visit per patient, 2-7 years after initial implantation]

    The primary endpoint of the study is hip stem survival, which is a common indicator for implant performance, which can also be used for comparison with implant registry data.

Secondary Outcome Measures

  1. Functional Outcome: Oxford Hip Score [One scheduled Follow-Up visit per patient, 2-7 years after initial implantation]

    The Oxford Hip Score is a 12-item questionnaire that assesses hip function and pain. The score ranges between 12 and 60, with a lower score indicating less disability

  2. Patient satisfaction with their endoprosthetic revision treatment [One scheduled Follow-Up visit per patient, 2-7 years after initial implantation]

    The Patients are asked to grade their level of satisfaction with the outcome of the surgery at time of follow-up, with the grades: "very dissatisfied", "dissatisfied", "satisfied", "very satisfied". The grades may be summarized as "satisfied" vs. "dissatisfied".

  3. Radiological evaluation (standard x-rays): Bone healing [One scheduled Follow-Up visit per patient, 2-7 years after initial implantation]

    Union of the osteotomy o Healing of the fracture and of the greater trochanter, if applicable

  4. Radiological evaluation (standard x-rays): osseointegration [One scheduled Follow-Up visit per patient, 2-7 years after initial implantation]

    Distal and proximal radiographic bone ingrowth and Qualitative proximal remodeling

  5. Radiological evaluation (standard x-rays): radiographic loosening [One scheduled Follow-Up visit per patient, 2-7 years after initial implantation]

    Signs of radiographic loosening in the distal fixation zone

  6. Radiological evaluation (standard x-rays): stem subsidence [One scheduled Follow-Up visit per patient, 2-7 years after initial implantation]

    Stem subsidence from ap x-rays using landmarks of the femur (typically lesser trochanter) and of the prosthesis

  7. Leg length difference [One scheduled Follow-Up visit per patient, 2-7 years after initial implantation]

    Discrepancy of leg length is often considered to be a problem after total hip replacement and can adversely affect an otherwise excellent outcome and may be associated with patient dissatisfaction.

  8. Descriptive Analysis of (Serious) adverse events [One scheduled Follow-Up visit per patient, 2-7 years after initial implantation]

    (Serious) adverse events that are potentially related to the Total hip arthroplasty (THA) procedure or the THA implants will be recorded. These are events as reported by the patient, observed in the follow-up examinations or taken from the patient record

Other Outcome Measures

  1. Descriptive Analysis of Patient characteristics [One scheduled Follow-Up visit per patient, 2-7 years after initial implantation]

    Age, weight, gender, date of surgery, indication for revision, comorbidities, intraoperative details

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • All patients implanted with a Prevision® hip stem at the study site between 2014 and 2019

  • Written informed patient consent

Exclusion Criteria:
  • Patients < 18 years at surgery

Contacts and Locations

Locations

Site City State Country Postal Code
1 Caritas-Krankenhaus Bad Mergentheim, Klinik für Orthopädie und Unfallchirurgie Bad Mergentheim Germany 97980

Sponsors and Collaborators

  • Aesculap AG

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Aesculap AG
ClinicalTrials.gov Identifier:
NCT04833634
Other Study ID Numbers:
  • AAG-O-H-2008
First Posted:
Apr 6, 2021
Last Update Posted:
Jun 16, 2022
Last Verified:
Jun 1, 2022

Study Results

No Results Posted as of Jun 16, 2022